Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

Efficacy and Mechanism Evaluation(2020)10.3310/eme07030Source: DataRank Database

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT is a research paper published in Efficacy and Mechanism Evaluation (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (18)IDs (PubMed)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Peter Connick ORCID,Richard Parker ORCID,Domenico Plantone ORCID,Anisha Doshi ORCID,Nevin John ORCID

Live enrichment

PubMed:26657633

European Commission

Grant: 601055

VPH Dementia Research Enabled by IT

UK Research and Innovation

Grant: MR/J01107X/1

EPICure@19 - the extremely preterm young adult

UK Research and Innovation

Grant: EP/J020990/1

Computational models of neurodegenerative disease progression

UK Research and Innovation

Grant: EP/H046410/1

Intelligent Imaging: Motion, Form and Function Across Scale

goldLicense: cc-by

publisherhttps://njl-admin.nihr.ac.uk/document/download/2032529

repositoryhttps://www.research.ed.ac.uk/en/publications/85f7b5ca-60a1-4cca-b662-7fc1ee7c71ce

repositoryhttps://doaj.org/article/1bf07b99cbbe44a4b0f26520d86e3ec8

repositoryhttps://www.journalslibrary.nihr.ac.uk/eme/eme07030#/abstract

https://doi.org/10.3310/eme07030

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

amiloridefluoxetineRdrug repositioningresearch designmultiple sclerosisriluzoleQPatrophymultiple sclerosis chronic progressivemagnetic resonance imagingMedicineneuroprotectionneurodegenerative diseasesRARC

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequality